Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.

View source ↗

Summary

Pfizer is enrolling pediatric patients in India to study somatrogon for growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somatrogon (somatrogon)

Snippet

Sponsor: Pfizer | Conditions: Dwarfism, Pituitary | Status: RECRUITING